Skip to search formSkip to main contentSkip to account menu

Difimicin

Known as: diffimicin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Tiacumicin Bfidaxomicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Tiacumicin Congeners with Improved Antibacterial Activity from a Halogenase-Inactivated Mutant.
Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clostridium difficile infections… 
Review
2014
Review
2014
Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection.
OBJECTIVE To review the chemistry, pharmacology, microbiology, pharmacodynamics, pharmacokinetics, clinical efficacy… 
Review
2012
Review
2012
Fidaxomicin: a new option for the treatment of Clostridium difficile infection.
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), namely vancomycin and… 
Review
2010
Review
2010
Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection
Objective: To evaluate the efficacy and safety of fidaxomicin for the treatment of Clostridium difficile infection. Data Sources… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)